BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26005324)

  • 1. Literature-based discovery of salivary biomarkers for type 2 diabetes mellitus.
    Srinivasan M; Blackburn C; Mohamed M; Sivagami AV; Blum J
    Biomark Insights; 2015; 10():39-45. PubMed ID: 26005324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers.
    Srinivasan M; Meadows ML; Maxwell L
    Biochem Res Int; 2018; 2018():7463796. PubMed ID: 29487749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and salivary ferritin and Hepcidin levels in patients with chronic periodontitis and type 2 diabetes mellitus.
    Guo LN; Yang YZ; Feng YZ
    BMC Oral Health; 2018 Apr; 18(1):63. PubMed ID: 29636044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary function impairment in type 2 Diabetes patients associated with concentration and genetic polymorphisms of chromogranin A.
    Kogawa EM; Grisi DC; Falcão DP; Amorim IA; Rezende TM; da Silva IC; Silva ON; Franco OL; de Amorim RF
    Clin Oral Investig; 2016 Nov; 20(8):2083-2095. PubMed ID: 26750135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of interlukin-6 and tumor necrosis factor-α in saliva of patients with type 2 diabetes mellitus and oral lichen planus].
    Liu Y; Jin JQ; Yuan ZF; Liu XS; Cao J; Guo XH; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):596-9. PubMed ID: 21844975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Salivary Butylated Hydroxytoluene and Ascorbic Acid Levels in Type 2 Diabetes Mellitus Patients.
    M I; Prethipa R; Kumar S L; Eswaramoorthy R; Kumar Vadivel J
    Cureus; 2024 Mar; 16(3):e56590. PubMed ID: 38646241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
    Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
    J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Salivary Osteopontin Levels with Glycaemic Status and Microalbuminuria - in Patients with Type 2 Diabetes Mellitus.
    Gopal N; Rajagambeeram R; Venkatkumar S; Vijayan MV; Murugaiyan SB; Gopal SP; Ramsamy S; Alwar V
    J Clin Diagn Res; 2016 Aug; 10(8):BC06-8. PubMed ID: 27656430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus.
    Feng JK; Lu YF; Li J; Qi YH; Yi ML; Ma DY
    Genet Mol Res; 2015 Mar; 14(1):2268-74. PubMed ID: 25867373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated glycomics strategy for the evaluation of glycosylation alterations in salivary proteins associated with type 2 diabetes mellitus.
    Yu H; Wang J; Tang Z; Li X; Yin M; Zhang F; Shu J; Chen W; Yang S; Li Z
    RSC Adv; 2020 Oct; 10(65):39739-39752. PubMed ID: 35515389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of glycemic control on oral health status in type 2 diabetes individuals and its association with salivary and plasma levels of chromogranin A.
    Kogawa EM; Grisi DC; Falcão DP; Amorim IA; Rezende TM; da Silva IC; Silva ON; Franco OL; de Amorim RF
    Arch Oral Biol; 2016 Feb; 62():10-9. PubMed ID: 26605682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy.
    Techatanawat S; Surarit R; Chairatvit K; Roytrakul S; Khovidhunkit W; Thanakun S; Izumi Y; Khovidhunkit SP
    Arch Oral Biol; 2019 Aug; 104():67-75. PubMed ID: 31174096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary biomarkers of oxidative stress: A critical review.
    Wang J; Schipper HM; Velly AM; Mohit S; Gornitsky M
    Free Radic Biol Med; 2015 Aug; 85():95-104. PubMed ID: 25889823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
    Zhang A; Sun H; Wang X
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic Stenosis Prognostication in Patients With Type 2 Diabetes: Protocol for Testing and Validation of a Biomarker-Derived Scoring System.
    Giritharan S; Cagampang F; Torrens C; Salhiyyah K; Duggan S; Ohri S
    JMIR Res Protoc; 2019 Aug; 8(8):e13186. PubMed ID: 31407670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Oxidative Stress Biomarkers in Clinical Studies on Type 2 Diabetes and Its Complications.
    Bigagli E; Lodovici M
    Oxid Med Cell Longev; 2019; 2019():5953685. PubMed ID: 31214280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intensity of free radical processes and chaperone activity in the saliva of patients with type 2 diabetes.
    Cheprasova AA; Popov SS; Pashkov AN; Verevkin AN; Mittova VO; Shulgin KK
    Biomedicine (Taipei); 2023; 13(2):56-61. PubMed ID: 37937300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.